Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis

AJNR. American Journal of Neuroradiology
C H SuhSang Joon Kim

Abstract

O6-methylguanine methyltransferase (MGMT) promoter methylation status has been reported as a prognostic biomarker in clinical trials. Our aim was to systematically evaluate imaging features of MGMT promoter methylated glioblastoma and to determine the diagnostic performance of MR imaging for prediction of MGMT promoter methylation in patients with newly diagnosed glioblastoma. A computerized search of Ovid MEDLINE and EMBASE up to February 27, 2018, was conducted. We selected studies evaluating imaging features of MGMT promoter methylated glioblastoma and the diagnostic performance of MR imaging for prediction of MGMT promoter methylation. Pooled estimates of sensitivity and specificity were calculated using a hierarchic logistic regression model. Meta-regression and sensitivity analysis were performed. Twenty-two articles including 2199 patients were included. MGMT promoter methylated glioblastoma is likely to show less edema, high ADC, and low perfusion. Ten articles including 753 patients were included in the meta-analysis. The summary sensitivity was 79% (95% CI, 72%-85%), and the summary specificity was 78% (95% CI, 71%-84%). In the meta-regression, MGMT promoter methylation and mean age were associated with heterogeneity....Continue Reading

References

Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Jul 5, 2002·BMC Medical Research Methodology·Walter L DevilléP Dick Bezemer
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marica EoliGaetano Finocchiaro
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alba A BrandesMario Ermani
Jan 5, 2012·BMC Cancer·Georgios IliadisGeorge Fountzilas
Jun 8, 2012·Journal of General Internal Medicine·Thomas A TrikalinosRongwei Fu
Nov 9, 2012·Neuro-oncology·Michael WellerWolfgang Wick
Aug 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin J van den BentPim J French
Feb 7, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael WellerUNKNOWN DIRECTOR Study Group
Nov 18, 2015·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Kyung Won KimSeong Ho Park
Nov 18, 2015·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Juneyoung LeeSeong Ho Park
Jan 23, 2016·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Chong Hyun Suh, Seong Ho Park
Jun 10, 2016·Medical Physics·Panagiotis KorfiatisBradley J Erickson
Mar 4, 2017·Computer Methods and Programs in Biomedicine·Vasileios G KanasRivka R Colen
Mar 16, 2017·The New England Journal of Medicine·James R PerryUNKNOWN Trial Investigators
Sep 20, 2017·Journal of Magnetic Resonance Imaging : JMRI·Yi-Bin XiHong Yin

❮ Previous
Next ❯

Citations

May 7, 2020·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Girolamo Crisi, Silvano Filice
Mar 6, 2021·AJNR. American Journal of Neuroradiology·C G B YoganandaJ A Maldjian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.